Published in J Biol Chem on October 16, 2000
The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity (2008) 10.55
Biology of interleukin-22. Semin Immunopathol (2010) 2.92
Pathological versus protective functions of IL-22 in airway inflammation are regulated by IL-17A. J Exp Med (2010) 2.30
A role for T cell-derived interleukin 22 in psoriatic skin inflammation. Clin Exp Immunol (2007) 2.16
Interferon-lambda: a new addition to an old family. J Interferon Cytokine Res (2010) 2.15
Parasites represent a major selective force for interleukin genes and shape the genetic predisposition to autoimmune conditions. J Exp Med (2009) 2.00
The level of TACI gene expression in myeloma cells is associated with a signature of microenvironment dependence versus a plasmablastic signature. Blood (2005) 1.96
Interleukin-10 suppression of myeloid cell activation--a continuing puzzle. Immunology (2004) 1.95
mda-7 (IL-24) Mediates selective apoptosis in human melanoma cells by inducing the coordinated overexpression of the GADD family of genes by means of p38 MAPK. Proc Natl Acad Sci U S A (2002) 1.91
The tyrosine kinase Tyk2 controls IFNAR1 cell surface expression. EMBO J (2003) 1.75
Structure and mechanism of receptor sharing by the IL-10R2 common chain. Structure (2010) 1.63
Interleukin-22: immunobiology and pathology. Annu Rev Immunol (2015) 1.60
Redundant and pathogenic roles for IL-22 in mycobacterial, protozoan, and helminth infections. J Immunol (2010) 1.53
A soluble class II cytokine receptor, IL-22RA2, is a naturally occurring IL-22 antagonist. Proc Natl Acad Sci U S A (2001) 1.43
Class II cytokine receptor gene cluster is a major locus for hepatitis B persistence. Proc Natl Acad Sci U S A (2006) 1.41
IL-22 Controls Iron-Dependent Nutritional Immunity Against Systemic Bacterial Infections. Sci Immunol (2017) 1.40
Elevated Th22 cells correlated with Th17 cells in patients with rheumatoid arthritis. J Clin Immunol (2011) 1.38
IL-22 is involved in liver regeneration after hepatectomy. Am J Physiol Gastrointest Liver Physiol (2009) 1.24
Structure of IL-22 bound to its high-affinity IL-22R1 chain. Structure (2008) 1.23
Aberrant expression of IL-22 receptor 1 and autocrine IL-22 stimulation contribute to tumorigenicity in ALK+ anaplastic large cell lymphoma. Leukemia (2008) 1.16
IL-22 is produced by innate lymphoid cells and limits inflammation in allergic airway disease. PLoS One (2011) 1.13
Development, regulation and functional capacities of Th17 cells. Semin Immunopathol (2010) 1.10
Lambda and alpha interferons inhibit hepatitis B virus replication through a common molecular mechanism but with different in vivo activities. Virology (2010) 1.10
Interferon-lambda1 (interleukin-29) preferentially down-regulates interleukin-13 over other T helper type 2 cytokine responses in vitro. Immunology (2008) 1.10
Inhibition of type I and type III interferons by a secreted glycoprotein from Yaba-like disease virus. Proc Natl Acad Sci U S A (2007) 1.08
Inhibition of interleukin-22 attenuates bacterial load and organ failure during acute polymicrobial sepsis. Infect Immun (2007) 1.06
Interleukin 22 signaling promotes cell growth in mantle cell lymphoma. Transl Oncol (2011) 1.03
Structural basis for receptor sharing and activation by interleukin-20 receptor-2 (IL-20R2) binding cytokines. Proc Natl Acad Sci U S A (2012) 1.03
Interleukin-26: an IL-10-related cytokine produced by Th17 cells. Cytokine Growth Factor Rev (2010) 1.03
Interleukin-24 and its receptors. Immunology (2005) 1.02
IL-22 is related to development of human colon cancer by activation of STAT3. BMC Cancer (2013) 1.01
Structural analysis of cytokines comprising the IL-10 family. Cytokine Growth Factor Rev (2010) 0.99
Interferon-λ in HCV Infection and Therapy. Viruses (2010) 0.98
A novel role for IL-22R1 as a driver of inflammation. Blood (2010) 0.98
IL-22 is mainly produced by IFNγ-secreting cells but is dispensable for host protection against Mycobacterium tuberculosis infection. PLoS One (2013) 0.97
New advances in molecular mechanisms and emerging therapeutic targets in alcoholic liver diseases. World J Gastroenterol (2014) 0.96
Expression of interleukin-22 in Sjögren's syndrome: significant correlation with disease parameters. Scand J Immunol (2011) 0.93
Pro-tumour activity of interleukin-22 in HPAFII human pancreatic cancer cells. Clin Exp Immunol (2012) 0.92
IL-22 contributes to TGF-β1-mediated epithelial-mesenchymal transition in asthmatic bronchial epithelial cells. Respir Res (2013) 0.92
IL-22 promotes fibroblast-mediated wound repair in the skin. J Invest Dermatol (2012) 0.91
Interleukin-22 reduces the severity of collagen-induced arthritis in association with increased levels of interleukin-10. Arthritis Rheum (2013) 0.90
Functional role of IL-22 in psoriatic arthritis. Arthritis Res Ther (2012) 0.89
Interleukin-21 induces the differentiation of human Tc22 cells via phosphorylation of signal transducers and activators of transcription. Immunology (2011) 0.89
Clinical consequences of targeting IL-17 and TH17 in autoimmune and allergic disorders. Curr Allergy Asthma Rep (2013) 0.87
IL-22 ameliorates renal ischemia-reperfusion injury by targeting proximal tubule epithelium. J Am Soc Nephrol (2014) 0.87
A tale of two cytokines: IL-17 and IL-22 in asthma and infection. Expert Rev Respir Med (2013) 0.86
Interleukin-22 forms dimers that are recognized by two interleukin-22R1 receptor chains. Biophys J (2007) 0.85
In vivo consequence of vitamin C insufficiency in liver injury: vitamin C ameliorates T-cell-mediated acute liver injury in gulo(-/-) mice. Antioxid Redox Signal (2013) 0.85
A restricted role for TYK2 catalytic activity in human cytokine responses revealed by novel TYK2-selective inhibitors. J Immunol (2013) 0.83
Endogenous IL-22 plays a dual role in arthritis: regulation of established arthritis via IFN-γ responses. PLoS One (2014) 0.82
IL-22 secreted by decidual stromal cells and NK cells promotes the survival of human trophoblasts. Int J Clin Exp Pathol (2013) 0.81
The current concept of T (h) 17 cells and their expanding role in systemic lupus erythematosus. Arthritis (2011) 0.81
Interleukin-22 as a molecular adjuvant facilitates IL-17-producing CD8+ T cell responses against a HBV DNA vaccine in mice. Hum Vaccin Immunother (2013) 0.80
Biological and pathological activities of interleukin-22. J Mol Med (Berl) (2016) 0.80
Interleukin-22 promotes T helper 1 (Th1)/Th17 immunity in chlamydial lung infection. Mol Med (2014) 0.80
Interleukin-22 is increased in multiple sclerosis patients and targets astrocytes. J Neuroinflammation (2015) 0.80
The molecular basis of IL-10 function: from receptor structure to the onset of signaling. Curr Top Microbiol Immunol (2014) 0.80
Association of Shp2 with phosphorylated IL-22R1 is required for interleukin-22-induced MAP kinase activation. J Mol Cell Biol (2010) 0.80
The Role of Interleukin-22 and Its Receptor in the Development and Pathogenesis of Experimental Autoimmune Uveitis. PLoS One (2016) 0.80
IL22/IL-22R pathway induces cell survival in human glioblastoma cells. PLoS One (2015) 0.79
L-22 enhances the invasiveness of endometrial stromal cells of adenomyosis in an autocrine manner. Int J Clin Exp Pathol (2014) 0.79
Curcumin inhibits proliferation of interleukin-22-treated HaCaT cells. Int J Clin Exp Med (2015) 0.78
IL-23 induces IL-22 and IL-17 production in response to Chlamydia muridarum genital tract infection, but the absence of these cytokines does not influence disease pathogenesis. Am J Reprod Immunol (2013) 0.78
Molecular modeling of the interleukin-19 receptor complex. Novel aspects of receptor recognition in the interleukin-10 cytokine family. J Mol Model (2004) 0.78
Blocking IL-22, a potential treatment strategy for adenomyosis by inhibiting crosstalk between vascular endothelial and endometrial stromal cells. Am J Transl Res (2015) 0.78
IL-22 promotes the migration and invasion of gastric cancer cells via IL-22R1/AKT/MMP-9 signaling. Int J Clin Exp Pathol (2014) 0.78
Differential Requirements for IL-17A and IL-22 in Cecal versus Colonic Inflammation Induced by Helicobacter hepaticus. Am J Pathol (2015) 0.78
Up-regulated Reg proteins induced by Interleukin-22 treatment ameliorate acute liver injury in rat model. Int J Clin Exp Med (2015) 0.77
Joint production of IL-22 participates in the initial phase of antigen-induced arthritis through IL-1β production. Arthritis Res Ther (2015) 0.77
Kaposi's sarcoma-associated herpesvirus-encoded LANA down-regulates IL-22R1 expression through a cis-acting element within the promoter region. PLoS One (2011) 0.77
Genetic polymorphisms and tissue expression of interleukin-22 associated with risk and therapeutic response of gastric mucosa-associated lymphoid tissue lymphoma. Blood Cancer J (2014) 0.77
Crystallization and preliminary X-ray diffraction analysis of human IL-22 bound to the extracellular IL-22R1 chain. Acta Crystallogr Sect F Struct Biol Cryst Commun (2008) 0.77
The crystal structure of zebrafish IL-22 reveals an evolutionary, conserved structure highly similar to that of human IL-22. Genes Immun (2014) 0.76
Endogenous interleukin-22 protects against inflammatory bowel disease but not autoimmune cholangitis in dominant negative form of transforming growth factor beta receptor type II mice. Clin Exp Immunol (2016) 0.76
IL-22 enhances CCL20 production in IL-1β-stimulated human gingival fibroblasts. Inflammation (2014) 0.76
New Approaches for Studying Alcoholic Liver Disease. Curr Pathobiol Rep (2014) 0.76
IL-22 regulation of functional gene expression in salivary gland cells. Genom Data (2015) 0.76
IL-22 negatively regulates Helicobacter pylori-induced CCL20 expression in gastric epithelial cells. PLoS One (2014) 0.76
Innate-like function of memory Th17 cells for enhancing endotoxin-induced acute lung inflammation through IL-22. Int Immunol (2015) 0.75
Interleukin-22 and Cyclosporine in Aggressive Cutaneous Squamous Cell Carcinoma. Dermatol Clin (2017) 0.75
Purification, crystallization and preliminary X-ray diffraction analysis of the IL-20-IL-20R1-IL-20R2 complex. Acta Crystallogr Sect F Struct Biol Cryst Commun (2011) 0.75
Hypoxic modulation of hepatocyte responses to the cytokine interleukin-22. Immunol Cell Biol (2016) 0.75
Expression of the inhibitory receptor NKG2A correlates with increased liver and splenic NK cell response to activating receptor engagement. Immun Inflamm Dis (2017) 0.75
Diagnostic value of interleukin 22 and carcinoembryonic antigen in tuberculous and malignant pleural effusions. Exp Ther Med (2011) 0.75
Crystallization and preliminary X-ray diffraction analysis of human IL-22 bound to its soluble decoy receptor IL-22BP. Acta Crystallogr Sect F Struct Biol Cryst Commun (2009) 0.75
During acute experimental infection with the reticulotropic Trypanosoma cruzi strain Tulahuen IL-22 is induced IL-23-dependently but is dispensable for protection. Sci Rep (2016) 0.75
Alternative splicing directs two IL-20R2 isoforms and is responsible for the incomplete gene knockout via the exon I ablation. Genes Immun (2016) 0.75
The Effects of IL-22 on the Inflammatory Mediator Production, Proliferation, and Barrier Function of HUVECs. Inflammation (2016) 0.75
Interferons and their actions. Annu Rev Biochem (1987) 8.36
Human leukocyte interferon produced by E. coli is biologically active. Nature (1980) 5.86
Inhibitors of ribosome functions. Annu Rev Microbiol (1971) 5.56
Synthesis of human fibroblast interferon by E. coli. Nucleic Acids Res (1980) 3.75
Convenient assay for interferons. J Virol (1981) 2.95
Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10). Proc Natl Acad Sci U S A (2000) 2.83
PRMT5 (Janus kinase-binding protein 1) catalyzes the formation of symmetric dimethylarginine residues in proteins. J Biol Chem (2001) 2.67
The interleukin-10 signal transduction pathway and regulation of gene expression in mononuclear phagocytes. J Interferon Cytokine Res (1999) 2.66
The human homologue of the yeast proteins Skb1 and Hsl7p interacts with Jak kinases and contains protein methyltransferase activity. J Biol Chem (1999) 2.64
Specific molecular activities of recombinant and hybrid leukocyte interferons. J Biol Chem (1982) 2.49
Cell-free translation of immunoglobulin messenger RNA from MOPC-315 plasmacytoma and MOPC-315 NR, a variant synthesizing only light chain. Proc Natl Acad Sci U S A (1975) 2.37
An antagonist peptide-EPO receptor complex suggests that receptor dimerization is not sufficient for activation. Nat Struct Biol (1998) 2.24
Intracellular serine protease of Bacillus subtilis: sequence homology with extracellular subtilisins. J Bacteriol (1978) 2.17
Synthesis of human interferon by Xenopus laevis oocytes: two structural genes for interferons in human cells. Proc Natl Acad Sci U S A (1977) 2.12
Anti-mRNA: specific inhibition of translation of single mRNA molecules. Proc Natl Acad Sci U S A (1984) 2.06
Biological properties of recombinant alpha-interferons: 40th anniversary of the discovery of interferons. Cancer Res (1998) 2.04
Identification and functional characterization of a second chain of the interleukin-10 receptor complex. EMBO J (1997) 2.03
Human leukocyte interferon: production, purification to homogeneity, and initial characterization. Proc Natl Acad Sci U S A (1979) 2.03
The RNA code and protein synthesis. Cold Spring Harb Symp Quant Biol (1966) 1.96
Induction and decay of human fibroblast interferon mRNA. Proc Natl Acad Sci U S A (1977) 1.94
Construction and identification of bacterial plasmids containing nucleotide sequence for human leukocyte interferon. Proc Natl Acad Sci U S A (1980) 1.92
Leukocyte interferon-induced tumor regression in human metastatic breast cancer, multiple myeloma, and malignant lymphoma. Ann Intern Med (1980) 1.91
Interleukin-10 inhibits expression of both interferon alpha- and interferon gamma- induced genes by suppressing tyrosine phosphorylation of STAT1. Blood (1999) 1.88
Efficient cloning of PCR generated DNA containing terminal restriction endonuclease recognition sites. Nucleic Acids Res (1990) 1.85
Binding of [14C]erythromycin to Escherichia coli ribosomes. Antimicrob Agents Chemother (1974) 1.83
Regulatory mechanisms and protein synthesis. X. Codon recognition on 30 S ribosomes. J Mol Biol (1966) 1.76
Studies on the formation of transfer ribonucleic acid-ribosome complexes. 3. The formation of peptide bonds by ribosomes in the absence of supernatant enzymes. J Biol Chem (1968) 1.76
Antibiotics as probes of ribosome structure: binding of chloramphenicol and erythromycin to polyribosomes; effect of other antibiotics. Antimicrob Agents Chemother (1974) 1.75
Expression and reconstitution of a biologically active human interferon-gamma receptor in hamster cells. J Biol Chem (1990) 1.70
Molecular genetic markers spanning mouse chromosome 10. Genomics (1990) 1.70
Studies on the formation of transfer ribonucleic acid-ribosome complexes. XXIV. Effects of antibiotics on binding of aminoacyl-oligonucleotides to ribosomes. J Biol Chem (1973) 1.69
Thiostrepton: a ribosomal inhibitor of translocation. Biochem Biophys Res Commun (1970) 1.67
Identification and sequence of an accessory factor required for activation of the human interferon gamma receptor. Cell (1994) 1.67
A JAK1/JAK2 chimera can sustain alpha and gamma interferon responses. Mol Cell Biol (1997) 1.62
Purification and characterization of recombinant human leukocyte interferon (IFLrA) with monoclonal antibodies. J Biol Chem (1981) 1.61
Partial interferon-gamma receptor signaling chain deficiency in a patient with bacille Calmette-Guérin and Mycobacterium abscessus infection. J Infect Dis (2000) 1.58
Cloning, expression and initial characterization of interleukin-19 (IL-19), a novel homologue of human interleukin-10 (IL-10). Genes Immun (2000) 1.58
Studies on the formation of transfer ribonucleic acid-ribosome complexes. VI. Oligopeptide synthesis and translocation on ribosomes in the presence and absence of soluble transfer factors. J Biol Chem (1969) 1.57
A convenient and rapid cytopathic effect inhibition assay for interferon. Methods Enzymol (1981) 1.56
Interferons inhibit activation of STAT6 by interleukin 4 in human monocytes by inducing SOCS-1 gene expression. Proc Natl Acad Sci U S A (1999) 1.50
Tumor cell responses to IFNgamma affect tumorigenicity and response to IL-12 therapy and antiangiogenesis. Immunity (1998) 1.49
Studies on transfer ribonucleic acid-ribosome complexes. XIX. Effect of antibiotics on peptidyl puromycin synthesis on polyribosoms from Escherichia coli. J Biol Chem (1972) 1.48
Transfer RNA species in normal and leukemic human lymphoblasts. J Mol Biol (1970) 1.41
Studies on the formation of transfer ribonucleic acid-ribosome complexes. XI. Antibiotic effects on phenylalanyl-oligonucleotide binding to ribosomes. Proc Natl Acad Sci U S A (1969) 1.39
Interferon-gamma receptor 2 expression as the deciding factor in human T, B, and myeloid cell proliferation or death. J Leukoc Biol (2001) 1.39
The use of inhibitors in studies on protein synthesis. Methods Enzymol (1974) 1.39
Peptidyl-puromycin synthesis on polyribosomes from Escherichia coli. Proc Natl Acad Sci U S A (1972) 1.39
Human leukocyte interferon: isolation and characterization of several molecular forms. Arch Biochem Biophys (1981) 1.38
Creation of phosphorylation sites in proteins: construction of a phosphorylatable human interferon alpha. Proc Natl Acad Sci U S A (1989) 1.36
Identification, cloning, and characterization of a novel soluble receptor that binds IL-22 and neutralizes its activity. J Immunol (2001) 1.35
The human interferons--from protein purification and sequence to cloning and expression in bacteria: before, between, and beyond. Arch Biochem Biophys (1983) 1.34
Thiostrepton-resistant mutants exhibit relaxed synthesis of RNA. Proc Natl Acad Sci U S A (1978) 1.33
Effect of erythromycin analogues on binding of [14C]erythromycin to Escherichia coli ribosomes. Antimicrob Agents Chemother (1974) 1.33
Interaction between the components of the interferon gamma receptor complex. J Biol Chem (1995) 1.32
Jak-Stat signal transduction pathway through the eyes of cytokine class II receptor complexes. Oncogene (2000) 1.31
Studies on the formation of transfer ribonucleic acid-ribosome complexes. 8. Survey of the effect of antibiotics of N-acetyl-phenylalanyl-puromycin formation: possible mechanism of chloramphenicol action. Arch Biochem Biophys (1970) 1.30
Inhibition of IL-12 production in human monocyte-derived macrophages by TNF. J Immunol (2000) 1.30
Amino acid sequence of a human leukocyte interferon. Proc Natl Acad Sci U S A (1981) 1.29
Cell-free synthesis of human interferon. Proc Natl Acad Sci U S A (1975) 1.29
The distance between two functionally significant regions of the 50 S Escherichia coli ribosome: the erythromycin binding site and proteins L7/L12. J Mol Biol (1976) 1.29
Targeted disruption of the interferon-gamma receptor 2 gene results in severe immune defects in mice. Proc Natl Acad Sci U S A (1998) 1.27
Interferon receptors. Immunol Today (1988) 1.27
Isolation and cell-free translation of immunoglobulin messenger RNA. Arch Biochem Biophys (1976) 1.26
Human chromosomes 6 and 21 are required for sensitivity to human interferon gamma. Proc Natl Acad Sci U S A (1987) 1.25
Purification and properties of serine protease from Halobacterium halobium. J Bacteriol (1983) 1.24
Intracellular serine protease from Bacillus subtilis. Structural comparison with extracellular serine proteases-subtilisins. Biochem Biophys Res Commun (1977) 1.23
A species of human alpha interferon that lacks the ability to boost human natural killer activity. Proc Natl Acad Sci U S A (1984) 1.23
Effects of combined treatment with interferon and mezerein on melanogenesis and growth in human melanoma cells. J Interferon Res (1985) 1.23
IL-4 reciprocally regulates IL-1 and IL-1 receptor antagonist expression in human monocytes. J Immunol (1992) 1.22
The interferon gamma (IFN-gamma) receptor: a paradigm for the multichain cytokine receptor. Cytokine Growth Factor Rev (1997) 1.20
Production of IL-10 by human natural killer cells stimulated with IL-2 and/or IL-12. J Immunol (1998) 1.20
Studies on transfer ribonucleic acid-ribosome complexes. XXI. Effect of antibiotics on peptidyl-puromycin synthesis by mammalian polyribosomes. J Biol Chem (1972) 1.20
Studies on the formation of transfer ribonucleic acid-ribosome complexes. 23. Chloramphenicol, aminoacyl-oligonucleotides, and Escherichia coli ribosomes. J Biol Chem (1972) 1.18
Differential IL-10R1 expression plays a critical role in IL-10-mediated immune regulation. J Immunol (2001) 1.18
Correlation of effects of erythromycin analogues on intact bacteria and on [14C]erythromycin binding to Escherichia coli ribosomes. Antimicrob Agents Chemother (1974) 1.16
Induction of erythromycin resistance in Staphyloccus aureus by erythromycin derivatives. Antimicrob Agents Chemother (1976) 1.16
A single amino acid determines the immunostimulatory activity of interleukin 10. J Exp Med (2000) 1.16
Definition and classification of the interferons. Methods Enzymol (1981) 1.14
Inhibition of protein synthesis in intact HeLa cells. Antimicrob Agents Chemother (1975) 1.14
The gene for the human immune interferon receptor is located on chromosome 6. Proc Natl Acad Sci U S A (1986) 1.14
Ligand-independent down-regulation of IFN-gamma receptor 1 following TCR engagement. J Immunol (2000) 1.13
Studies on the formation of trensfer ribonucleic acid-ribosome complexes. V. On the function of a soluble transfer factor in protein synthesis. Proc Natl Acad Sci U S A (1968) 1.13
De novo synthesis and glycosylation of the MOPC-46B mouse immunoglobulin light chain in cell-free extracts. J Biol Chem (1977) 1.12
Effects of several species of human leukocyte interferon on cytotoxic activity of NK cells and monocytes. Int J Cancer (1983) 1.12